Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Circulation|February 8, 2021
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF TrialMichael E Nassif, Mohammed Qintar, Sheryl L Windsor, et al.
European Journal of Heart Failure|July 18, 2024
Safety and efficacy of aficamten in patients with non-obstructive hypertrophic cardiomyopathy: A 36-week analysis from FOREST-HCMAhmad Masri, Roberto Barriales-Villa, Perry Elliott, et al.
Heart (British Cardiac Society)|January 22, 2015
Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacementBrian R Lindman, Jacob S Goldstein, Michael E Nassif, et al.
European Journal of Heart Failure|February 21, 2025
Low blood pressure and the effect of empagliflozin in acute heart failure: An EMPULSE analysisJoão Pedro Ferreira, Francisco Vasques-Nóvoa, Christiane E Angermann, et al.
Journal of Cardiac Failure|March 23, 2021
PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic CorrelatesYasser Sammour, Christopher Dezorzi, Bethany A Austin, et al.
European Heart Journal|October 18, 2022
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trialJan Biegus, Adriaan A Voors, Sean P Collins, et al.
European Journal of Heart Failure|April 4, 2024
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trialJasper Tromp, Mikhail N Kosiborod, Christiane E Angermann, et al.
European Journal of Heart Failure|February 20, 2021
Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trialJasper Tromp, Piotr Ponikowski, Afshin Salsali, et al.
JACC. Heart Failure|March 7, 2026
Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSEChristiane E Angermann, Teresa Gerhardt, Jonathan P Blatchford, et al.
European Journal of Heart Failure|September 6, 2022
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trialAdriaan A Voors, Kevin Damman, John R Teerlink, et al.
Pageof 9